Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Cell Technology, Inc.
Advanced Cell Technology and CHA Bio & Diostech to Collaborate on RPE Technology Development in Korea
April 17th, 2009
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) and a leading Korea-based stem cell company, CHA Bio & Diostech Co., Ltd. (CHA Bio), formerly CHA Biotech, Co., Ltd., announced that the parties have entered into a licensing agreement under which Advanced Cell will license its retinal pigment epithelium (RPE) technology, for the treatment of diseases of the eye, to CHA Bio for development and commercialization exclusively in Korea. ACT is eligible to receive up to a total of $1.9 million in fees based upon the parties achieving certain milestones, including ACT making an IND submission to the US FDA to commence clinical trials in humans using the technology, which ACT...
Source: Health Business Week (2009-04-17)
|
|
Advertisement |
 |
- 141 Capital, Inc. Positioned for Continued Success in the Trading Arena
- Bankruptcy Court Judge Grants All First-Day Motions in 1800mattress.com Chapter 11 Proceeding
- BBC World News Joins the 1Cast Network
- Music from the Motion Picture 'The Lifting of the Veil' Is Officially Released on iTunes and Other Online Stores by 2 Republic Music Group, Which Is Operated by the 20-Year-Old South Asian Music Mogul C
- 24-7StockAlert.net is Pleased to Offer an Explosive Stock Alerts Service
- 24-7StockAlert.net Offers Hot Stock Alert on Today's Largest Percentage Movers - ACOR, FSLR, NOK, C, BAC, GOOG, AMLN, APOL, JPM, IBM C
|
 |
|
|
|
